Vantive is a vital organ therapy company that specialises in dialysis and critical care therapies. The company supports dialysis both at home and in clinical settings and provides vital organ support in intensive care units. It operates globally, serving patients in more than 100 countries and managing over one million daily patient touchpoints.
The company's portfolio includes digitally-enhanced solutions and remote patient monitoring technology. Its remote monitoring platform is associated with lower mortality rates, fewer hospitalisations, reduced treatment drop-out, and greater adherence for home dialysis patients.
Founded in 2025, Vantive builds upon a 70-year legacy of kidney care innovation. The organisation is mission-driven, with a stated focus on extending lives and expanding possibilities for patients and care teams. Technical domains span vital organ therapies, critical care, and digitally-enhanced solutions.
